Re: Encouraging covid vaccine uptake and safe behaviours—an uphill struggle against government complacency
Dear Editor
'Padmanabhan Bandrinath says in his r.r. 'The government has also been very transparent by publishing all the data including vaccination statistics. Lay media has used the publicly accessible information to provide detailed analysis to its readership, BBC (7) being a classical example. The public can drill down to a postcode level on cases and vaccination rates among other things.
Unfortunately what is significantly missing from information available to any of us is the trial data without which properly informed decisions cannot be made. Even regulators do not necessarily even yet ,have access to the trials data . If more people come to realise that the information made publicly available relies on such partial information they may have even less confidence and trust. The way forward needs to be to publish the trial data . Thebmj published an important article in August.
'There is inadequate availability of COVID-19 vaccine trial documents and data; individual participant data will not be available for months, perhaps years, for most vaccines. Widespread use of interventions without full data transparency raises concerns over the rational use of COVID-19 vaccines.8 Aug 2021'
Reference:- Transparency of COVID-19 vaccine trials: decisions without data.
Rapid Response:
Re: Encouraging covid vaccine uptake and safe behaviours—an uphill struggle against government complacency
Dear Editor
'Padmanabhan Bandrinath says in his r.r. 'The government has also been very transparent by publishing all the data including vaccination statistics. Lay media has used the publicly accessible information to provide detailed analysis to its readership, BBC (7) being a classical example. The public can drill down to a postcode level on cases and vaccination rates among other things.
Unfortunately what is significantly missing from information available to any of us is the trial data without which properly informed decisions cannot be made. Even regulators do not necessarily even yet ,have access to the trials data . If more people come to realise that the information made publicly available relies on such partial information they may have even less confidence and trust. The way forward needs to be to publish the trial data . Thebmj published an important article in August.
'There is inadequate availability of COVID-19 vaccine trial documents and data; individual participant data will not be available for months, perhaps years, for most vaccines. Widespread use of interventions without full data transparency raises concerns over the rational use of COVID-19 vaccines.8 Aug 2021'
Reference:- Transparency of COVID-19 vaccine trials: decisions without data.
Competing interests: No competing interests